What is Adamax?
Adamax is offered by peptide suppliers as a modified version of Semax (Met-Glu-His-Phe-Pro-Gly-Pro). Supplier descriptions usually say it is Semax with an acetylated N-terminus and an adamantane group added at the C-terminus, intended to make the peptide more resistant to breakdown. These descriptions are not consistent with one another, and we have not found a peer-reviewed publication that defines Adamax’s structure or reports studies on it.
Because of this, we recommend that you request the certificate of analysis for your batch, which states the identity and purity as tested.
Adamax product specifications
- Compound: Adamax (reported Semax analogue)
- Sequence and structure: not established in peer-reviewed literature; see the batch certificate of analysis
- Vial sizes: 5mg and 10mg
- Form: lyophilised powder
Available sizes: 5mg and 10mg
Adamax is offered in two vial sizes: 5mg and 10mg. Both contain the same peptide. The figure is the total amount of peptide in the vial, supplied as a dry (lyophilised) powder; it is not a concentration, so a larger vial is not “stronger”, it simply holds more material. Tell us which size you need when you contact us on Telegram or by email.
Related peptides
- Semax, the parent peptide, which has published research behind it.
- N-Acetyl Semax, an N-terminally acetylated form of Semax.
- The Semax and Selank blend.
Regulatory status
Adamax is not approved as a medicine anywhere. It is research material sold for laboratory research use only.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.
